Effects of bolus injection of esmolol in healthy, exercising subjects
- 1 April 1987
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 41 (4) , 455-459
- https://doi.org/10.1038/clpt.1987.56
Abstract
Esmolol is an investigational ultra-short-acting .beta.-adrenergic blocker that has potential application in many clinical cardiology settings. The purpose of this study was to investigate the effect of bolus dose of esmolol on heart rate, blood pressure, and PR interval in healthy, exercising male subjects. We gave a single esmolol bolus over 30 seconds to 13 men who exercised to a predetermined target heart rate. Each subject performed the exercise protocol twice, receiving a different dose between 10 and 300 mg each time. An additional eight subjects received two esmolol boluses 5 minutes apart while performing the same exercise protocol. Esmolol doses of 180 mg or greater caused a 13% to 18% decrease in heart rate, an 11% to 18% decrease in blood pressure, and a 13% to 22% prolongation of the PR interval. The median time to peak esmolol effect was 1 minute for heart rate, 2 minutes for blood pressure, and 4 minutes for PR interval. The median time required to recover 50%, 75%, and 90% of the decrement in heart rate was 8, 10, and 13 minutes, respectively. The rapid onset and disappearance of esmolol effects may make it in appealing drug in acute care settings.This publication has 8 references indexed in Scilit:
- Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trialAmerican Heart Journal, 1985
- Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.Circulation, 1985
- Safety and efficacy of esmolol (ASL-8052: An ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardiasJournal of the American College of Cardiology, 1984
- Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metaboliteClinical Pharmacology & Therapeutics, 1983
- Hemodynamic and adrenergic responses to anesthesia and operation for myocardial revascularizationThe Journal of Thoracic and Cardiovascular Surgery, 1980
- Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.Journal of Clinical Investigation, 1980
- Control of Heart Rate by the Autonomic Nervous SystemCirculation Research, 1966
- Effects of atrial and ventricular tachycardias on the cardiovascular dynamicsAmerican Journal of Physiology-Legacy Content, 1964